(1)
Lauppe, R.; Nilsson, F. O. L.; Fues Wahl, H.; Lilja, M.; Vikström, A.; Asanin, S. T. Use of ALK-Tyrosine Kinase Inhibitors (ALK TKI) in Clinical Practice, Overall Survival, and Treatment Duration – a Swedish Nationwide Retrospective Study. AO 2022, 61, 1354-1361.